Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Norwalk Vaccine Study

This study has been completed.
Information provided by (Responsible Party):
LigoCyte Pharmaceuticals, Inc. Identifier:
First received: September 8, 2009
Last updated: May 21, 2012
Last verified: July 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
No publications provided by LigoCyte Pharmaceuticals, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):